Warsaw, Mazowieckie, Poland
🎯 Open to opportunities where I can apply my skills and mindset in fresh ways – whether in drug discovery or in new professional areas that value analytical thinking, collaboration and scientific curiosity. 👨🔬 I’m a biologist and experienced research scientist with a strong track record in non-clinical oncology, experimental immunology, microbiology and in vivo pharmacology. My professional pathway has been shaped by curiosity, analytical precision and a deep commitment to quality science. 🧠 My core expertise: — In vivo models of cancer and inflammation, PK/PD studies, biomarker discovery — Molecular biology, microbiology and immunology (including immuno-oncology and vaccine research) — Scientific documentation, regulatory submissions (animal studies), mentoring and training 💡 Strengths and working style: — Analytical mindset with hands-on experience in biostatistics and data-driven decision making — Structured and detail-oriented approach to research and project execution — Empathetic communicator with a strong team spirit and high reliability under pressure — Independent in my scientific thinking, yet always open to feedback and growth 📚 Scientific track record: — PhD in biology (microbiology & immunology) — First author of 5 original peer-reviewed publications — Co-author of 20+ other scientific papers — Co-inventor on 2 patents related to small-molecule arginase inhibitors — ORCID profile: https://orcid.org/0000-0002-5197-7538 🤝 I value working in teams driven by clarity, purpose and mutual respect - where I can apply my strengths to meaningful, real-world challenges.
Working on quality control of antimicrobial susceptibility testing (AST) systems, focusing on method validation, standardization and compliance with EUCAST/CLSI guidelines.
✅ Designed and performed experiments leading to high-impact publications ✅ Scientific support for the clinical development of OATD-02 (ClinicalTrials.gov: NCT05759923) ✅ Co-leader of an undisclosed project on mRNA-targeting small-molecule therapeutics ✅ Prepared applications for animal studies to the local ethics committee; collaborated with external CROs and animal facilities ✅ Led the in vivo pharmacology group and mentored new team members in animal research and assay development ✅ Optimized animal models (syngeneic and xenograft tumor models, inflammatory disease models) for pharmacological testing ✅ Performed and analyzed PK/PD and efficacy experiments in various therapeutic areas ✅ Developed and refined enzymatic and cell-based assays, improving project outcomes ✅ Led pharmacodynamic and metabolomic studies on tumor microenvironment remodeling
✅ Co-led the OATD-02 arginase inhibitor project during its transition to the clinical stage ✅ Supported IND-enabling studies and liaised with the non-clinical safety team ✅ First author of the key publication validating OATD-02 as a dual arginase inhibitor with anticancer activity
✅ Biology co-lead of the arginase inhibitor project (OATD-02), responsible for experimental planning and execution ✅ Designed and conducted in vivo studies in syngeneic and xenograft tumor models ✅ Initiated and coordinated collaborations with academic groups to expand pharmacological profiling ✅ Co-authored several publications on arginase inhibition and immune modulation in cancer